Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00478218

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

NCT00317798

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00004908

Conditions: Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

NCT01423032

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Prof. Dr. Norbert Niederle Leverkusen, North Rhine-Westphalia, Germany

View Trial Details

Completed

Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475

Conditions: Anxiety Disorder, Anxiety Disorders, Blast Crisis, +87 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

NCT01418430

Conditions: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL), Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: King's College Hospital NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma

NCT00569868

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

NCT00273936

Conditions: Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations: Arizona Clinical Research Center Tucson, Arizona, United States

Stanford Cancer Center Stanford, California, United States

George Washington University Washington D.C., District of Columbia, United States

Ohio State University, James Cancer Hospital Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

NCT00006219

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

NCT00004075

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions